These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 11753450

  • 1. [Activity of itraconazole against clinical isolates of Aspergillus spp. and Fusarium spp. determined by the M38-P NCCLS method].
    Carrillo-Muñoz AJ, Quindós G, Ruesga M, Brió S, del Valle O, Rodríguez V, Hernández-Molina JM, Cantón E, Pemán J, Santos P.
    Rev Esp Quimioter; 2001 Sep; 14(3):281-5. PubMed ID: 11753450
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the Sensititre YeastOne colorimetric antifungal panel and Etest with the NCCLS M38-A method to determine the activity of amphotericin B and itraconazole against clinical isolates of Aspergillus spp.
    Martín-Mazuelos E, Pemán J, Valverde A, Chaves M, Serrano MC, Cantón E.
    J Antimicrob Chemother; 2003 Sep; 52(3):365-70. PubMed ID: 12917236
    [Abstract] [Full Text] [Related]

  • 3. In vitro activity of terbinafine and itraconazole against Aspergillus species isolated from otomycosis.
    Karaarslan A, Arikan S, Ozcan M, Ozcan KM.
    Mycoses; 2004 Aug; 47(7):284-7. PubMed ID: 15310330
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi.
    Espinel-Ingroff A.
    J Clin Microbiol; 2001 Apr; 39(4):1360-7. PubMed ID: 11283057
    [Abstract] [Full Text] [Related]

  • 5. Use of spectrophotometric reading for in vitro antifungal susceptibility testing of Aspergillus spp.
    Dannaoui E, Persat F, Monier MF, Borel E, Piens MA, Picot S.
    Can J Microbiol; 1999 Oct; 45(10):871-4. PubMed ID: 10907424
    [Abstract] [Full Text] [Related]

  • 6. In vitro susceptibility of Aspergillus spp. clinical isolates to albendazole.
    Berthet N, Faure O, Bakri A, Ambroise-Thomas P, Grillot R, Brugère JF.
    J Antimicrob Chemother; 2003 Jun; 51(6):1419-22. PubMed ID: 12716778
    [Abstract] [Full Text] [Related]

  • 7. In vitro susceptibility testing of Candida and Aspergillus spp. to voriconazole and other antifungal agents using Etest: results of a French multicentre study.
    Mallié M, Bastide JM, Blancard A, Bonnin A, Bretagne S, Cambon M, Chandenier J, Chauveau V, Couprie B, Datry A, Feuilhade M, Grillot R, Guiguen C, Lavarde V, Letscher V, Linas MD, Michel A, Morin O, Paugam A, Piens MA, Raberin H, Tissot E, Toubas D, Wade A.
    Int J Antimicrob Agents; 2005 Apr; 25(4):321-8. PubMed ID: 15784312
    [Abstract] [Full Text] [Related]

  • 8. Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species.
    Meletiadis J, Mouton JW, Meis JF, Bouman BA, Donnelly PJ, Verweij PE, EUROFUNG Network.
    J Clin Microbiol; 2001 Dec; 39(12):4256-63. PubMed ID: 11724829
    [Abstract] [Full Text] [Related]

  • 9. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole.
    Kaya AD, Kiraz N.
    Mycoses; 2007 Nov; 50(6):447-50. PubMed ID: 17944704
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro pharmacodynamics of amphotericin B, itraconazole, and voriconazole against Aspergillus, Fusarium, and Scedosporium spp.
    Lewis RE, Wiederhold NP, Klepser ME.
    Antimicrob Agents Chemother; 2005 Mar; 49(3):945-51. PubMed ID: 15728887
    [Abstract] [Full Text] [Related]

  • 12. In vitro interactions of antifungal agents against clinical isolates of Fusarium spp.
    Córdoba S, Rodero L, Vivot W, Abrantes R, Davel G, Vitale RG.
    Int J Antimicrob Agents; 2008 Feb; 31(2):171-4. PubMed ID: 18054469
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species.
    Arikan S, Lozano-Chiu M, Paetznick V, Nangia S, Rex JH.
    J Clin Microbiol; 1999 Dec; 37(12):3946-51. PubMed ID: 10565912
    [Abstract] [Full Text] [Related]

  • 16. In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole.
    Dannaoui E, Persat F, Monier MF, Borel E, Piens MA, Picot S.
    J Antimicrob Chemother; 1999 Oct; 44(4):553-5. PubMed ID: 10588320
    [Abstract] [Full Text] [Related]

  • 17. Antifungal activity of amphotericin B and itraconazole against filamentous fungi: comparison of the Sensititre Yeast One and NCCLS M38--a reference methods.
    Carrillo-Muñoz AJ, Quindós G, Del Valle O, Hernández-Molina JM, Santos P.
    J Chemother; 2004 Oct; 16(5):468-73. PubMed ID: 15565914
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi.
    Garcia-Effron G, Gomez-Lopez A, Mellado E, Monzon A, Rodriguez-Tudela JL, Cuenca-Estrella M.
    J Antimicrob Chemother; 2004 Jun; 53(6):1086-9. PubMed ID: 15102749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.